Global Drug Abuse Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Drug Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Drug Abuse Testing market size is estimated to be worth US$ 6322 million in 2021 and is forecast to a readjusted size of USD 9732 million by 2028 with a CAGR of 6.4% during review period. Schools and Educational Institutes accounting for % of the Drug Abuse Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Random Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Drug Abuse Testing include Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, and Dako, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug Abuse Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Random Testing
Reasonable Testing
Post accident Testing
Follow-up Testing
Market segment by Application, can be divided into
Schools and Educational Institutes
Hospitals and Healthcare Units
Government and Private Departments
Market segment by players, this report covers
Biomedical Diagnostics
BioMerieux
Abbott
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Beckman Coulter
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Drug Abuse Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Drug Abuse Testing, with revenue, gross margin and global market share of Drug Abuse Testing from 2019 to 2022.
Chapter 3, the Drug Abuse Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Drug Abuse Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Drug Abuse Testing research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Drug Abuse Testing
1.2 Classification of Drug Abuse Testing by Type
1.2.1 Overview: Global Drug Abuse Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Drug Abuse Testing Revenue Market Share by Type in 2021
1.2.3 Random Testing
1.2.4 Reasonable Testing
1.2.5 Post accident Testing
1.2.6 Follow-up Testing
1.3 Global Drug Abuse Testing Market by Application
1.3.1 Overview: Global Drug Abuse Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Schools and Educational Institutes
1.3.3 Hospitals and Healthcare Units
1.3.4 Government and Private Departments
1.4 Global Drug Abuse Testing Market Size & Forecast
1.5 Global Drug Abuse Testing Market Size and Forecast by Region
1.5.1 Global Drug Abuse Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Drug Abuse Testing Market Size by Region, (2017-2022)
1.5.3 North America Drug Abuse Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Drug Abuse Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Drug Abuse Testing Market Size and Prospect (2017-2028)
1.5.6 South America Drug Abuse Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Drug Abuse Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Abuse Testing Market Drivers
1.6.2 Drug Abuse Testing Market Restraints
1.6.3 Drug Abuse Testing Trends Analysis
2 Company Profiles
2.1 Biomedical Diagnostics
2.1.1 Biomedical Diagnostics Details
2.1.2 Biomedical Diagnostics Major Business
2.1.3 Biomedical Diagnostics Drug Abuse Testing Product and Solutions
2.1.4 Biomedical Diagnostics Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biomedical Diagnostics Recent Developments and Future Plans
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux Drug Abuse Testing Product and Solutions
2.2.4 BioMerieux Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 BioMerieux Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Drug Abuse Testing Product and Solutions
2.3.4 Abbott Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Bio-Rad
2.4.1 Bio-Rad Details
2.4.2 Bio-Rad Major Business
2.4.3 Bio-Rad Drug Abuse Testing Product and Solutions
2.4.4 Bio-Rad Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Bio-Rad Recent Developments and Future Plans
2.5 Dako
2.5.1 Dako Details
2.5.2 Dako Major Business
2.5.3 Dako Drug Abuse Testing Product and Solutions
2.5.4 Dako Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Dako Recent Developments and Future Plans
2.6 DiaSorin
2.6.1 DiaSorin Details
2.6.2 DiaSorin Major Business
2.6.3 DiaSorin Drug Abuse Testing Product and Solutions
2.6.4 DiaSorin Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 DiaSorin Recent Developments and Future Plans
2.7 Eiken
2.7.1 Eiken Details
2.7.2 Eiken Major Business
2.7.3 Eiken Drug Abuse Testing Product and Solutions
2.7.4 Eiken Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Eiken Recent Developments and Future Plans
2.8 Fujirebio
2.8.1 Fujirebio Details
2.8.2 Fujirebio Major Business
2.8.3 Fujirebio Drug Abuse Testing Product and Solutions
2.8.4 Fujirebio Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fujirebio Recent Developments and Future Plans
2.9 Beckman Coulter
2.9.1 Beckman Coulter Details
2.9.2 Beckman Coulter Major Business
2.9.3 Beckman Coulter Drug Abuse Testing Product and Solutions
2.9.4 Beckman Coulter Drug Abuse Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Beckman Coulter Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug Abuse Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Drug Abuse Testing Players Market Share in 2021
3.2.2 Top 10 Drug Abuse Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Drug Abuse Testing Players Head Office, Products and Services Provided
3.4 Drug Abuse Testing Mergers & Acquisitions
3.5 Drug Abuse Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drug Abuse Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Drug Abuse Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Drug Abuse Testing Revenue Market Share by Application (2017-2022)
5.2 Global Drug Abuse Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Drug Abuse Testing Revenue by Type (2017-2028)
6.2 North America Drug Abuse Testing Revenue by Application (2017-2028)
6.3 North America Drug Abuse Testing Market Size by Country
6.3.1 North America Drug Abuse Testing Revenue by Country (2017-2028)
6.3.2 United States Drug Abuse Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Drug Abuse Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Drug Abuse Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Drug Abuse Testing Revenue by Type (2017-2028)
7.2 Europe Drug Abuse Testing Revenue by Application (2017-2028)
7.3 Europe Drug Abuse Testing Market Size by Country
7.3.1 Europe Drug Abuse Testing Revenue by Country (2017-2028)
7.3.2 Germany Drug Abuse Testing Market Size and Forecast (2017-2028)
7.3.3 France Drug Abuse Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Drug Abuse Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Drug Abuse Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Drug Abuse Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drug Abuse Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Drug Abuse Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Drug Abuse Testing Market Size by Region
8.3.1 Asia-Pacific Drug Abuse Testing Revenue by Region (2017-2028)
8.3.2 China Drug Abuse Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Drug Abuse Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Drug Abuse Testing Market Size and Forecast (2017-2028)
8.3.5 India Drug Abuse Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Drug Abuse Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Drug Abuse Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Drug Abuse Testing Revenue by Type (2017-2028)
9.2 South America Drug Abuse Testing Revenue by Application (2017-2028)
9.3 South America Drug Abuse Testing Market Size by Country
9.3.1 South America Drug Abuse Testing Revenue by Country (2017-2028)
9.3.2 Brazil Drug Abuse Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Drug Abuse Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drug Abuse Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Drug Abuse Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Drug Abuse Testing Market Size by Country
10.3.1 Middle East & Africa Drug Abuse Testing Revenue by Country (2017-2028)
10.3.2 Turkey Drug Abuse Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Drug Abuse Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Drug Abuse Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Drug Abuse Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Drug Abuse Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Drug Abuse Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Drug Abuse Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Drug Abuse Testing Revenue Market Share by Region (2023-2028)
Table 6. Biomedical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 7. Biomedical Diagnostics Major Business
Table 8. Biomedical Diagnostics Drug Abuse Testing Product and Solutions
Table 9. Biomedical Diagnostics Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 11. BioMerieux Major Business
Table 12. BioMerieux Drug Abuse Testing Product and Solutions
Table 13. BioMerieux Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott Drug Abuse Testing Product and Solutions
Table 17. Abbott Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 19. Bio-Rad Major Business
Table 20. Bio-Rad Drug Abuse Testing Product and Solutions
Table 21. Bio-Rad Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Dako Corporate Information, Head Office, and Major Competitors
Table 23. Dako Major Business
Table 24. Dako Drug Abuse Testing Product and Solutions
Table 25. Dako Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 27. DiaSorin Major Business
Table 28. DiaSorin Drug Abuse Testing Product and Solutions
Table 29. DiaSorin Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Eiken Corporate Information, Head Office, and Major Competitors
Table 31. Eiken Major Business
Table 32. Eiken Drug Abuse Testing Product and Solutions
Table 33. Eiken Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 35. Fujirebio Major Business
Table 36. Fujirebio Drug Abuse Testing Product and Solutions
Table 37. Fujirebio Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 39. Beckman Coulter Major Business
Table 40. Beckman Coulter Drug Abuse Testing Product and Solutions
Table 41. Beckman Coulter Drug Abuse Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Global Drug Abuse Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 43. Global Drug Abuse Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 44. Breakdown of Drug Abuse Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Drug Abuse Testing Players Head Office, Products and Services Provided
Table 46. Drug Abuse Testing Mergers & Acquisitions in the Past Five Years
Table 47. Drug Abuse Testing New Entrants and Expansion Plans
Table 48. Global Drug Abuse Testing Revenue (USD Million) by Type (2017-2022)
Table 49. Global Drug Abuse Testing Revenue Share by Type (2017-2022)
Table 50. Global Drug Abuse Testing Revenue Forecast by Type (2023-2028)
Table 51. Global Drug Abuse Testing Revenue by Application (2017-2022)
Table 52. Global Drug Abuse Testing Revenue Forecast by Application (2023-2028)
Table 53. North America Drug Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 54. North America Drug Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 55. North America Drug Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 56. North America Drug Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 57. North America Drug Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 58. North America Drug Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 59. Europe Drug Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 60. Europe Drug Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 61. Europe Drug Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 62. Europe Drug Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 63. Europe Drug Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 64. Europe Drug Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 65. Asia-Pacific Drug Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. Asia-Pacific Drug Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. Asia-Pacific Drug Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. Asia-Pacific Drug Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. Asia-Pacific Drug Abuse Testing Revenue by Region (2017-2022) & (USD Million)
Table 70. Asia-Pacific Drug Abuse Testing Revenue by Region (2023-2028) & (USD Million)
Table 71. South America Drug Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 72. South America Drug Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 73. South America Drug Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 74. South America Drug Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 75. South America Drug Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 76. South America Drug Abuse Testing Revenue by Country (2023-2028) & (USD Million)
Table 77. Middle East & Africa Drug Abuse Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. Middle East & Africa Drug Abuse Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. Middle East & Africa Drug Abuse Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. Middle East & Africa Drug Abuse Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. Middle East & Africa Drug Abuse Testing Revenue by Country (2017-2022) & (USD Million)
Table 82. Middle East & Africa Drug Abuse Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Drug Abuse Testing Picture
Figure 2. Global Drug Abuse Testing Revenue Market Share by Type in 2021
Figure 3. Random Testing
Figure 4. Reasonable Testing
Figure 5. Post accident Testing
Figure 6. Follow-up Testing
Figure 7. Drug Abuse Testing Revenue Market Share by Application in 2021
Figure 8. Schools and Educational Institutes Picture
Figure 9. Hospitals and Healthcare Units Picture
Figure 10. Government and Private Departments Picture
Figure 11. Global Drug Abuse Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Drug Abuse Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Drug Abuse Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Drug Abuse Testing Revenue Market Share by Region in 2021
Figure 15. North America Drug Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Drug Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Drug Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Drug Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Drug Abuse Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Drug Abuse Testing Market Drivers
Figure 21. Drug Abuse Testing Market Restraints
Figure 22. Drug Abuse Testing Market Trends
Figure 23. Biomedical Diagnostics Recent Developments and Future Plans
Figure 24. BioMerieux Recent Developments and Future Plans
Figure 25. Abbott Recent Developments and Future Plans
Figure 26. Bio-Rad Recent Developments and Future Plans
Figure 27. Dako Recent Developments and Future Plans
Figure 28. DiaSorin Recent Developments and Future Plans
Figure 29. Eiken Recent Developments and Future Plans
Figure 30. Fujirebio Recent Developments and Future Plans
Figure 31. Beckman Coulter Recent Developments and Future Plans
Figure 32. Global Drug Abuse Testing Revenue Share by Players in 2021
Figure 33. Drug Abuse Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players Drug Abuse Testing Revenue Market Share in 2021
Figure 35. Global Top 10 Players Drug Abuse Testing Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global Drug Abuse Testing Revenue Share by Type in 2021
Figure 38. Global Drug Abuse Testing Market Share Forecast by Type (2023-2028)
Figure 39. Global Drug Abuse Testing Revenue Share by Application in 2021
Figure 40. Global Drug Abuse Testing Market Share Forecast by Application (2023-2028)
Figure 41. North America Drug Abuse Testing Sales Market Share by Type (2017-2028)
Figure 42. North America Drug Abuse Testing Sales Market Share by Application (2017-2028)
Figure 43. North America Drug Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 44. United States Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Drug Abuse Testing Sales Market Share by Type (2017-2028)
Figure 48. Europe Drug Abuse Testing Sales Market Share by Application (2017-2028)
Figure 49. Europe Drug Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 50. Germany Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Drug Abuse Testing Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific Drug Abuse Testing Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Drug Abuse Testing Revenue Market Share by Region (2017-2028)
Figure 58. China Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Drug Abuse Testing Sales Market Share by Type (2017-2028)
Figure 65. South America Drug Abuse Testing Sales Market Share by Application (2017-2028)
Figure 66. South America Drug Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa Drug Abuse Testing Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa Drug Abuse Testing Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa Drug Abuse Testing Revenue Market Share by Country (2017-2028)
Figure 72. Turkey Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE Drug Abuse Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
